Sullivan is applied across domains where additional symptomatic support is needed. It is considered relevant in contexts involving heightened systemic burden. The use of symptomatic management is often relevant for short-term assistance with distressing symptoms.

---

Support for Acute and Disruptive Symptoms

Sullivan is generally used in situations involving certain distressing symptoms and is applied when symptoms create noticeable functional strain. It helps address symptom clusters that may become intense or disruptive, and is relevant in areas where short-term symptom management is appropriate. It supports the patient during difficult episodes by easing distress. The medication is commonly used across conditions presenting with acute episodes, recurrent or episodic manifestations, and situations involving significant symptomatic burden.

“Sullivan is applied when additional support is needed to help ease the overall symptom burden.”

---

Promoting Comfort and Functional Support

This medication contributes to improved comfort during periods of heightened symptoms. It helps maintain a sense of stability when symptoms are more noticeable and assists with maintaining functional stability.

---

Quick Fact: Relief for Episodic Discomfort Sullivan is commonly used to help manage symptoms linked to episodic or fluctuating manifestations and those associated with acute or disruptive changes.

Regulatory References

1. National Institute of Mental Health (NIMH) guidance

Sullivan is generally allowed for use in adults, children, and older adults, though eligibility is strictly defined by regulatory criteria. The medicine is subject to absolute contraindications that strictly prohibit its use in certain populations.

Eligibility Scope

Populations for whom use is contraindicated:

• Patients with a history of serious hypersensitivity reaction to any penicillin, cephalosporin, or other beta-lactam drug.
• Patients with a previous history of cholestatic jaundice or liver dysfunction associated with this specific medicine.

Condition-Specific Eligibility Rules:

• Severe Renal Impairment: Use is restricted, and the extended-release tablet formulation is contraindicated for patients with severe impairment.
• Infectious Mononucleosis: The medicine is not recommended for patients with this condition.
• Pregnancy and Lactation: Use during pregnancy is not recommended unless considered essential. It may be used with caution during breastfeeding.

This eligibility profile establishes non-negotiable exclusions and defines conditional use parameters based on organ function and specific concurrent conditions, thereby regulating who can and cannot use the medicine.

Interactions with other medicines and products

The interaction profile for Sullivan (Amoxicillin/Clavulanate Potassium) is based strictly on pharmacokinetic changes, pharmacodynamic risks, and administration requirements documented in regulatory labeling.

---

Pharmacokinetic and Transporter Interactions

Co-administration with Probenecid is associated with a pharmacokinetic interaction that decreases the renal tubular secretion of amoxicillin, resulting in its increased and prolonged plasma concentrations. For this reason, regulatory documents state that use with Probenecid is not recommended.

---

Pharmacodynamic and Risk Modifiers

The co-administration of Sullivan with oral anticoagulants (e.g., Warfarin) may increase the prolongation of prothrombin time, a documented risk requiring caution. Additionally, taking the medicine concurrently with Allopurinol is noted to increase the likelihood of allergic skin reactions (rash).

---

Administration and Special Cautions

The medicine should be administered at the start of a meal to enhance the absorption of the clavulanate component and minimize gastrointestinal intolerance, as meal timing affects absorption. The medicine may reduce the efficacy of oral contraceptives, a caution included in official documents. Furthermore, high concentrations of amoxicillin may cause false-positive results when performing certain non-enzymatic urine glucose tests, and the clavulanic acid component may cause a false positive Coombs test.

Blocking Bacterial Folate Synthesis at the Source

Sullivan's core action is a competitive inhibition directed at the bacterial enzyme dihydropteroate synthase (DHPS). Structurally mimicking the enzyme's natural substrate, para-aminobenzoic acid (PABA), the drug occupies the active site of DHPS, thereby blocking the initial step of the de novo folate synthesis pathway. This molecular interaction results in a deficiency of DNA and RNA precursors within the target bacteria.

Preventing Microbial DNA and RNA Replication

The blocked folate pathway initiates a mechanistic cascade that prevents the formation of essential purine and pyrimidine bases. This fundamental intracellular process ultimately leads to a halt in the organism's ability to create new genetic material. The resulting physiological effect is the suppression of bacterial growth and division (bacteriostasis).

️ Selectivity in Targeting Microbial Metabolism

This mechanism demonstrates selectivity by exclusively targeting a microbial metabolic pathway not present in human hosts. The drug's efficacy relies on the bacteria's requirement for de novo folate synthesis, a process absent in human cells, whose folate requirements are obtained via dietary intake.

How Sullivan Is Used: Official Administration Guidelines

Sullivan (Amoxicillin/Clavulanate) is administered according to specific patterns that govern route, dosing, and duration. It is primarily used through the oral route (tablets, suspension) but can also be administered intravenously (IV) for more severe initial treatment.

---

Dosing and Frequency

Standard oral dosing for adults (geq 40 kg) typically follows a twice-daily (every 12 hours) or three-times-daily (every 8 hours) schedule, depending on the chosen strength and the context of use. The standard 875 mg/125 mg tablet strength is generally taken every 12 hours. Pediatric dosing (for patients < 40 kg) is calculated based on the milligram-per-kilogram (mg/kg) of the amoxicillin component. Treatment duration is typically set for 5 to 14 days and must not exceed 14 days without clinical reassessment.

---

Contextual and Population-Specific Requirements

Proper use requires that the medicine be taken at the start of a meal; this instruction is designed to optimize drug absorption and minimize gastrointestinal intolerance. For patients with renal impairment, the dosing frequency must be reduced based on the degree of creatinine clearance (CrCl); for example, patients with CrCl < 30 mL/min should avoid the 875 mg/125 mg strength.

When preparing the oral suspension, the powder must be reconstituted with water and shaken vigorously. The dose must be measured precisely using a calibrated measuring device to ensure accurate delivery of the labeled strength. Specific strengths are not interchangeable; for instance, two 250 mg/125 mg tablets cannot substitute for one 500 mg/125 mg tablet because of differing clavulanate ratios.

Sullivan: Recent Clinical Evidence

Phase III Clinical Data

Studies have been conducted to evaluate the effects of the combination of Drug X and Drug Y in individuals with chronic, non-cancer pain. Safety findings for this combination were reported across the reviewed studies.

A large-scale Phase III trial (N=1,200) assessed the effects of Drug X combined with Drug Y on reported pain scores and quality of life measures after 8 weeks. Observations regarding the study endpoints were recorded throughout the 1-year follow-up period. Furthermore, studies investigated the effects of the combination on the reported use of opioid medication.

---

Pharmacological and Exploratory Research

Two smaller, investigator-initiated studies (N=150 total) were conducted to understand the biological activity of Drug X when administered with Drug Y. These studies provided observations regarding how the effects of the individual drugs may relate when administered together.

For populations where chronic pain is comorbid with anxiety, research has evaluated the results reported with this combination, considering that Drug Y has been the subject of research focusing on anxiolytic effects. The available data in this area, based on the studies reviewed, is limited.

---

Conclusion of Evidence Review

Across the reviewed studies, research reports that the combination of Drug X and Drug Y has been investigated for use in chronic, non-cancer pain. The majority of published evidence describes trials that have assessed the reported study endpoints for pain and quality of life measures. Further research is required to fully characterize long-term outcomes and biological activity.

Key Studies & References

1. National Institute for Health and Care Excellence (NICE) Guideline: Management of Chronic Primary Pain

Common questions about Sullivan (FAQ)

Q: Is Sullivan a type of antibiotic, pain killer, or something else?

A: Sullivan is officially classified as a fixed-dose combination antibiotic. It contains two active ingredients: Amoxicillin, which kills bacteria, and Clavulanic Acid, which protects the first component from bacterial defenses. Its sole purpose is to treat bacterial infections as defined in its regulatory indications.

Q: Is there a generic version of Sullivan available yet?

A: Yes, the combination of amoxicillin and clavulanate potassium, the active ingredients in Sullivan, is widely available. Regulatory agencies have approved and listed generic versions of the drug from multiple manufacturers, in addition to brand-name versions.

Q: How quickly can someone expect to notice the effects of Sullivan?

A: Official documents indicate that the active components are rapidly and well absorbed after administration, typically reaching their highest concentration in the blood within about one hour. The time it takes for a person to notice an improvement in their symptoms can vary and depends on the specific type and severity of the infection being treated.

Q: Does Sullivan keep working if I stop taking it for a few days?

A: Official instructions emphasize the importance of using the drug according to the full prescribed course. Stopping the medicine early can risk the infection recurring and may also contribute to the concerning public health issue of antibiotic resistance.

Q: Is Sullivan known to be hard on the stomach or digestive system?

A: Official safety information indicates that gastrointestinal disorders are the most common adverse effects associated with this medicine. Diarrhea, in particular, is listed as a Very Common event, alongside nausea and vomiting being Common.

Q: Why do some people say Sullivan makes them feel dizzy?

A: Dizziness is listed in the official documentation as an Uncommon side effect of this medicine. It is classified as an effect on the central nervous system, which is a documented occurrence during use.

Q: Is Sullivan prescribed for children and teenagers?

A: Yes, the medicine is approved and indicated for use in children and teenagers when appropriate for treating a bacterial infection. Official dosing is specifically calculated for pediatric patients based on their body weight and infection severity.

Q: Can Sullivan affect birth control pills?

A: Yes, regulatory warnings explicitly include a caution that this medicine may reduce the efficacy of oral contraceptives. This potential interaction is generally discussed by healthcare professionals during prescribing.

Q: How long does Sullivan stay in your system after stopping treatment?

A: Official pharmacokinetic information states that the half-life of the active ingredients is approximately one hour for both amoxicillin and clavulanic acid. This means the drug is generally eliminated from the body relatively quickly after the final dose is administered.

Q: Can Sullivan make you feel more tired than usual?

A: Fatigue or feeling unusually tired is not typically listed as one of the most common side effects of this medicine. However, official safety information does document reports of central nervous system effects, which can sometimes include non-specific feelings of being unwell.

Q: Is Sullivan considered a high-risk medication?

A: Regulatory safety information documents the potential for serious, occasionally fatal, systemic reactions. These potential risks include severe allergic (hypersensitivity) reactions and serious liver dysfunction, which is why specific contraindications are in place.

Q: Can I get Sullivan without a prescription in some countries?

A: No, this medicine is legally classified as a Prescription Only Medicine (℞-only) by all major regulatory bodies worldwide. It cannot be legally obtained without a valid prescription from a licensed healthcare professional.

Q: Is it normal to have mild headaches when first starting Sullivan?

A: Headache is a documented adverse event for this medicine. Official documents list headache as an Uncommon side effect that a person may experience while taking the drug.

Q: Can I drive or operate machinery while taking Sullivan?

A: Official patient information advises caution regarding the operation of complex machinery or driving. This standard warning is given because potential side effects, such as dizziness, may affect a person's abilities.

Q: Are there different strengths of Sullivan tablets available?

A: Yes, the medicine is available in several different strengths and forms, including both solid tablets and oral suspension for mixing. The specific strength prescribed depends on the type of infection and the patient's age and weight.

Q: What kind of monitoring (blood tests) is required when using Sullivan?

A: Regulatory documents recommend periodic monitoring of liver, kidney, and blood-forming function. This monitoring is typically advised when the medicine is used for prolonged periods, especially due to the potential for severe hepatobiliary effects.

Q: Can men and women use Sullivan for the same purposes?

A: Yes, the medicine is indicated to treat the same types of bacterial infections in both men and women. However, documented safety information does note that hepatic adverse events (liver-related issues) are reported more often in males and older patients.

Q: Is Sullivan a federally controlled substance?

A: No, this medicine is not classified as a federally controlled substance by regulatory agencies. It is regulated strictly as a Prescription Only Medicine.

Q: Does taking Sullivan affect the results of any lab tests?

A: Official warnings confirm that the medicine can potentially affect the results of certain lab tests. This includes the possibility of false-positive results in specific non-enzymatic urine glucose tests and a false positive Coombs test.

Q: What if Sullivan doesn't seem to be working for me after a few weeks?

A: Regulatory documents define a limited treatment duration, typically ranging from 5 to 14 days. If the infection requires treatment to extend past this 14-day period, official guidance indicates that clinical reassessment is required.

Q: Is Sullivan a new drug, or has it been around for a while?

A: The active combination of amoxicillin and clavulanic acid is not a new medicine. It has been used for several decades, with its original launch in the UK occurring in 1981.

Q: What if I accidentally take two doses of Sullivan close together?

A: The overdosage section of official regulatory documents notes that taking high doses can be associated with the risk of crystalluria. Crystalluria is the formation of crystals in the urine, which carries the potential for kidney effects.

Q: Is it safe to drink alcohol while taking Sullivan?

A: Official regulatory warnings do not specifically list alcohol as a substance that is contraindicated with this medicine. Official patient guides universally advise discussing any alcohol consumption, allowing a professional to review the individual's specific circumstances.

Q: Does Sullivan affect sleep or cause insomnia?

A: According to the official product information reviewed by regulatory bodies, insomnia (difficulty sleeping) is listed as an uncommon side effect of this medicine. Changes in sleep patterns should be discussed with a healthcare professional.

Q: Is Sullivan safe to take if I have kidney problems?

A: Official product information describes the requirement for caution in individuals with kidney impairment. Dosing adjustments are explicitly required for patients with severe kidney problems, and the extended-release formulation of this drug is strictly contraindicated in this population.

Q: Can Sullivan be used by people with liver conditions?

A: Regulatory warnings confirm that the medicine must be used with caution in individuals who have evidence of existing liver dysfunction. It is strictly forbidden for anyone with a prior history of liver issues, such as cholestatic jaundice, that was previously associated with taking this specific medicine.

Q: What research studies support the use of Sullivan?

A: The use of Sullivan is fully supported by extensive clinical trials and data submitted to regulatory agencies worldwide. This evidence demonstrates the drug's efficacy and safety profile as a fixed-dose combination antibiotic for treating various bacterial infections as defined in its approved indications.

Q: Is Sullivan safe for women who are planning to become pregnant?

A: Official guidance addresses the use of the medicine during pregnancy, stating it is generally not recommended unless a healthcare professional considers it absolutely essential. While specific details on the pre-conception planning stage are not detailed, professional consultation is typically advised to review individual risk.

Q: Does Sullivan interact with grapefruit or grapefruit juice?

A: The official regulatory interaction profile for this medicine does not list grapefruit or grapefruit juice as a specific substance to avoid. Established interactions listed in official documents focus on other specific drugs and foods, such as meal timing.

Storage Conditions

Official storage instructions for Amoxicillin and Clavulanate Potassium differ by formulation:

Formulation	Required Storage Condition
Tablets / Dry Powder	Store at controlled room temperature (e.g., 20 C to 25 C) and protect from light and moisture in the original container.
Reconstituted Suspension	Must be stored under refrigeration (e.g., 2 C to 8 C). Do not freeze.

The liquid suspension is only stable for 10 days after mixing and must be discarded after this period.

Handling and Disposal

All forms of the medicine must be stored out of the reach and sight of children. Unused or expired medication should be disposed of in accordance with local pharmaceutical waste regulations.